Boerhinger funds ADA initiative

Share this article:

Boehringer Ingelheim is sponsoring a collaborative research project with the American Diabetes Association to improve the evidence base for and clinical care of patients with chronic kidney disease and diabetes.

The three-year commitment includes $1.5 million from Boehringer, which will be managed by the ADA.

“Diabetes is the leading cause of kidney failure, accounting for more than 40% of new cases,” the American Diabetes Association's president of medicine and science Elizabeth Seaquist said in a statement.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.